Anti-Infective Agents Market Report 2021-2031
Rising incidences of infectious diseases is one of the prime factors driving the growth of the global anti-infective agents market...Full DetailsPUBLISHED: 11 May 2021Antiviral Drugs Treatment Market Report 2021-2031
Rising incidences of viral infection; increasing geriatric population is projected to propel the demand for anti-viral drugs; advancement in anti-viral...Full DetailsPUBLISHED: 26 April 2021Antibiotics Market Report 2021-2031
The rising prevalence of tuberculosis, malaria, pneumonia, bacterial skin infections, HIV/AIDS, urinary tract infections (UTI), and other diseases will support...Full DetailsPUBLISHED: 15 April 2021Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031
Rising prevalence of inflammatory bowel disease including Crohn's disease and ulcerative colitis; raising awareness for IBD in developing countries; escalating...Full DetailsPUBLISHED: 06 April 2021Cancer Biologics Therapies Market Report 2021-2031
The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or...Full DetailsPUBLISHED: 01 April 2021European Antibiotics Market Report 2021-2031
Penicillin segment holds majority of the market share owing to maximum prescription as well as the most generic manufacturers throughout...Full DetailsPUBLISHED: 31 March 2021Inhalation & Nasal Spray Generic Drugs Market Report 2021-2031
Rising prevalence of chronic respiratory diseases including asthma, COPD, and allergic rhinitis; rising geriatric population, escalating investment in drug R&D...Full DetailsPUBLISHED: 22 March 2021Antisense Oligonucleotide (ASO) Therapeutics Market Report 2021-2031
Over the last few years, the antisense oligonucleotide therapeutics has gained widespread attention due to the technological advancements and growth...Full DetailsPUBLISHED: 17 March 2021Animal Hormones Market Report to 2031
Increasing the prevalence of hormonal lack of sicknesses, for instance, Addison illness in animals is a dominant factor that pushes...Animal Antimicrobials and Antibiotics Market Report to 2031
Spending on pet healthcare in the U.S. remains high. As per the American Pet Products Association (APPA), veterinary care is...
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Antibiotics Market Report 2023-2033
The antibiotics market was valued at US$44,567.3 million in 2022 and is projected to grow at a CAGR of 4.15% during the forecast period 2023-2033.
31 January 2023
Visiongain Publishes Clinical Trial Supplies Market Report 2023-2033
The global Clinical Trial Supplies market was valued at US$ 2,617.7 million in 2022 and is projected to grow at a CAGR of 9.32% during the forecast period 2023-2033.
31 January 2023
Visiongain Publishes Meningococcal Vaccines Market Report 2023-2033
The global Meningococcal Vaccines market was valued at US$3,268.6 million in 2022 and is projected to grow at a CAGR of 6.32% during the forecast period 2023-2033.
31 January 2023
Visiongain Publishes Human Microbiome Market Report 2023-2033
The global Human Microbiome market was valued at US$186.8 million in 2022 and is projected to grow at a CAGR of 25% during the forecast period 2023-2033.
30 January 2023
